Business Description
![Hologic Inc Hologic Inc logo](https://static.gurufocus.com/logos/0C00000BB3.png?14)
Hologic Inc
NAICS : 334517
SIC : 3844
ISIN : BRH1OLBDR004
Share Class Description:
BSP:H1OL34: BRDRDescription
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.85 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.53 | |||||
Debt-to-EBITDA | 2.59 | |||||
Interest Coverage | 5.97 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.08 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.3 | |||||
3-Year EBITDA Growth Rate | -7.5 | |||||
3-Year EPS without NRI Growth Rate | -2.4 | |||||
3-Year FCF Growth Rate | 9 | |||||
3-Year Book Growth Rate | 25.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 7.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.73 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.91 | |||||
14-Day RSI | 99.38 | |||||
6-1 Month Momentum % | 3.41 | |||||
12-1 Month Momentum % | -10.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.97 | |||||
Quick Ratio | 3.29 | |||||
Cash Ratio | 2.28 | |||||
Days Inventory | 120.31 | |||||
Days Sales Outstanding | 61.64 | |||||
Days Payable | 34.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 2.1 | |||||
Shareholder Yield % | 6.86 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.93 | |||||
Operating Margin % | 17.19 | |||||
Net Margin % | 11.78 | |||||
FCF Margin % | 23.95 | |||||
ROE % | 9.33 | |||||
ROA % | 5.17 | |||||
ROIC % | 9.53 | |||||
ROC (Joel Greenblatt) % | 57 | |||||
ROCE % | 8.41 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 36.44 | |||||
Forward PE Ratio | 16.41 | |||||
PE Ratio without NRI | 19.37 | |||||
Shiller PE Ratio | 25.72 | |||||
Price-to-Owner-Earnings | 30.49 | |||||
PEG Ratio | 0.36 | |||||
PS Ratio | 4.38 | |||||
PB Ratio | 3.44 | |||||
Price-to-Tangible-Book | 20.82 | |||||
Price-to-Free-Cash-Flow | 18.29 | |||||
Price-to-Operating-Cash-Flow | 15.73 | |||||
EV-to-EBIT | 25.3 | |||||
EV-to-Forward-EBIT | 14.44 | |||||
EV-to-EBITDA | 17.18 | |||||
EV-to-Forward-EBITDA | 13.84 | |||||
EV-to-Revenue | 4.31 | |||||
EV-to-Forward-Revenue | 4.38 | |||||
EV-to-FCF | 17.98 | |||||
Price-to-Projected-FCF | 1.06 | |||||
Price-to-Median-PS-Value | 1.12 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.77 | |||||
Price-to-Graham-Number | 4.23 | |||||
Earnings Yield (Greenblatt) % | 3.95 | |||||
FCF Yield % | 5.69 | |||||
Forward Rate of Return (Yacktman) % | 26.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hologic Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 19,478.962 | ||
EPS (TTM) (R$) | 9.682 | ||
Beta | -0.11 | ||
Volatility % | 15.97 | ||
14-Day RSI | 99.38 | ||
14-Day ATR (R$) | 0.00286 | ||
20-Day SMA (R$) | 366.3 | ||
12-1 Month Momentum % | -10.44 | ||
52-Week Range (R$) | 337.29 - 409 | ||
Shares Outstanding (Mil) | 233.38 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hologic Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hologic Inc Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
Hologic Inc Frequently Asked Questions
What is Hologic Inc(BSP:H1OL34)'s stock price today?
The current price of BSP:H1OL34 is R$366.30. The 52 week high of BSP:H1OL34 is R$409.00 and 52 week low is R$337.29.
When is next earnings date of Hologic Inc(BSP:H1OL34)?
The next earnings date of Hologic Inc(BSP:H1OL34) is 2024-07-31 Est..
Does Hologic Inc(BSP:H1OL34) pay dividends? If so, how much?
Hologic Inc(BSP:H1OL34) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |